169 related articles for article (PubMed ID: 7772705)
1. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.
Lühder F; Schlosser M; Mauch L; Haubruck H; Rjasanowski I; Michaelis D; Kohnert KD; Ziegler M
Autoimmunity; 1994; 19(2):71-80. PubMed ID: 7772705
[TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies to the 65-kD isoform of glutamate decarboxylase by radioimmunoassay.
Lühder F; Woltanski KP; Mauch L; Haubruck H; Kohnert KD; Rjasanowski I; Michaelis D; Ziegler M
Eur J Endocrinol; 1994 Jun; 130(6):575-80. PubMed ID: 8205257
[TBL] [Abstract][Full Text] [Related]
3. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
[TBL] [Abstract][Full Text] [Related]
4. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
[TBL] [Abstract][Full Text] [Related]
5. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
[TBL] [Abstract][Full Text] [Related]
6. Immune reactivity to GAD25 in type 1 diabetes mellitus.
Chessler SD; Hampe CS; Ortqvist E; Simonson WT; Bekris L
Autoimmunity; 2002 Aug; 35(5):335-41. PubMed ID: 12515288
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
8. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies.
Marcovina SM; Landin-Olsson M; Essen-Möller A; Palmer JP; Lernmark A
Int J Clin Lab Res; 2000; 30(1):21-6. PubMed ID: 10984128
[TBL] [Abstract][Full Text] [Related]
11. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
14. Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
Kawasaki E; Yano M; Abiru N; Akazawa S; Nagataki S
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):61-9. PubMed ID: 8803483
[TBL] [Abstract][Full Text] [Related]
15. A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies.
Tiberti C; Falorni A; Torresi P; Vecci E; Anastasi E; Dotta F; Di Mario U
J Immunol Methods; 1997 Sep; 207(2):107-13. PubMed ID: 9368637
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes.
Jayakrishnan B; Hoke DE; Langendorf CG; Buckle AM; Rowley MJ
PLoS One; 2011 Apr; 6(4):e18411. PubMed ID: 21494613
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].
Cinek O; Pechová M; Kolousková S; Horká I; Sedláková P; Sumník Z; Snajderová M; Vavrinec J
Cas Lek Cesk; 2000 Sep; 139(19):599-603. PubMed ID: 11192752
[TBL] [Abstract][Full Text] [Related]
19. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
